Company Aggregate Debt: microbotmedical.com (MBOT)

Symbol and logo of brand Microbot Medical (MBOT)

This chart of the cost of debt for Microbot Medical Inc. (MBOT) currently stands at 0.00. Microbot Medical Inc. (MBOT) develops robotic systems for microsurgery, planning to monetize the sale and servicing of systems for endovascular interventions. As the business remains in the pre-commercial stage, scaling profits is currently impossible, while the costs of launching clinical trials remain extremely high.

Company Aggregate Debts: Microbot Medical Inc. (MBOT) for 07/04/2022 - 10/27/2026

Metric breakdowns and analytics for Microbot Medical (MBOT)

- price and consensus price forecast:
Market Price Microbot Medical, Inc|MBOT - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Microbot Medical Inc|MBOT - Enterprise Value
- book capitalization data:
Net Assets per Share Microbot Medical|MBOT - Book Capitalization|Market Cap to Net Assets Ratio microbotmedical.com|MBOT - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Microbot Medical Inc.|MBOT - Long-Term Debt to Equity|Short-Term Debt to Equity Microbot Medical, Inc.|MBOT - Company Total Debt|Debt to Net Assets Ratio Microbot Medical Inc
Basic company analysis:MBOT Microbot Medical, Inc
Product sample of Microbot Medical, Inc.

A defensive portfolio requires strict leverage control to minimize bankruptcy risks. This metric aggregates all long-term and short-term borrowings, reflecting the total cost of external financing. For Microbot Medical Inc. (MBOT), such resources are critical for the development of Liberty microrobots in collaboration with cardiology centers. An optimal balance of debt capital ensures a technological leap without compromising stability. By analyzing the current level of liabilities, an investor assesses the issuer's financial autonomy.

Key competitors

Company Cumulative Debt Intuitive Corp (ISRG)|DHR - Company Aggregate Debts|Company Aggregate Debt bd.com BDX|Company Aggregate Debts STE (STERIS)|WST - Company Total Debt Obligations|BAX (Baxter Corp) - Company Aggregate Debts|Masimo Inc. (MASI) - Company Total Debt|STVN (Stevanato Group S.p.A.) - Company Aggregate Debts|Company Aggregate Debts TFX|Company Debts Merit Medical (MMSI)|Company Debts Envista Holdings Corporation NVST|Company Total Debt ICU Medical Corp|Aggregate Debt Obligations Sirona Dental Systems XRAY|Company Aggregate Debts LMAT (LeMaitre Vascular, Inc.)|ATRC: Company Total Debt Obligations|Company Debts STAAR Surgical|NAGE (ChromaDex Corporation) - Company Aggregate Debt|ZIMV: Company Debts|Company Total Debt Obligations AngioDynamics Inc. (ANGO)|Company Total Debt Cerus Corporation|Company Cumulative Indebtedness TKNO (teknova.com)|Company Debts Monogram Orthopedics|STSS - Aggregate Debt Obligations|InfuSystem Inc - Company Total Debt|UTMD: Company Aggregate Debts|KRMD (korumedical.com) - Company Debts|nyxoah.com (NYXH) - Company Total Debt|Company Aggregate Debts PDEX (Pro-Dex)|Company Cumulative Debt ZTEK|Company Debts Elutia Corp ELUT|Company Aggregate Debt Milestone Scientific Corporation MLSS|Company Total Debt NEXGEL, Inc. (NXGL)|Retractable Technologies Inc. - Company Cumulative Indebtedness|Company Debts HBIO (Harvard Bioscience)|FEMY: Company Total Debt Obligations|MHUA (meihuamed.com) - Company Debts|Predictive Oncology Inc. (POAI) - Company Total Debt|CJMB: Company Aggregate Debts|Company Total Debt Obligations atrioncorp.com|Company Aggregate Debts NURO (NeuroMetrix)